The survival outcomes of molecular glioblastoma IDH-wildtype: a multicenter study. Ramos-Fresnedo A, Pullen MW, Perez-Vega C, Domingo RA, et al. J Neurooncol 2022 Feb 17. pii: 10.1007/s11060-022-03960.

Read + Share

Amedeo Smart

Independent Medical Education

Ramos-Fresnedo A, Pullen MW, Perez-Vega C, Domingo RA, et al. The survival outcomes of molecular glioblastoma IDH-wildtype: a multicenter study. J Neurooncol 2022 Feb 17. pii: 10.1007/s11060-022-03960.
PMID: 35175545